Companies
SKAN AG
- Country
- Switzerland
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Acquisitions funded through a new revolving credit facility (RCF) | ir.skan.com |
| Production site | Allschwil (Switzerland), Görlitz (Germany), Gembloux (Belgium), Stein (Switzerland) | ir-api.eqs.com · ir.skan.com |
| Certification | ISO 9001:2015, Great Place to Work certification | ir-api.eqs.com · skan.com |
| Headcount | 1,694 (as of June 30, 2026); 1,700 (as of February 2026) | skan.com · eqs-news.com |
| Revenue | CHF 333.3 million (2025 financial year) | stockanalysis.com · eqs-news.com · ir.skan.com |
| Regulatory approval | Solutions comply with EU-GMP Annex 1, FDA, and ISO standards; individual drug products filled in AT-Closed Vials have received 17-19 approvals from major authorities | ir-api.eqs.com · skan.com · eqs-news.com |
Independent sources: eqs-news.com · ir-api.eqs.com · ir.skan.com · stockanalysis.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Aseptic isolators for pharma manufacturing | analytics-pat | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.